Statins and primary liver cancer (original) (raw)
Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
Mohaimenul Islam
Cancers
View PDFchevron_right
Statin use and risk of hepatocellular carcinoma
Hsueh-chou Lai
European Journal of Epidemiology, 2013
View PDFchevron_right
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh
Gastroenterology, 2013
View PDFchevron_right
Statins and Reduced Risk of Liver Cancer: Evidence for Confounding: Table 1
Bruce Fireman
Journal of the National Cancer Institute, 2016
View PDFchevron_right
Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies
Argirios Tsantes
British Journal of Clinical Pharmacology, 2007
View PDFchevron_right
Statin Use and the Risk of Liver Cancer: A Population-Based Case–Control Study
Chih-cheng Chen
American Journal of Gastroenterology, 2010
View PDFchevron_right
Do statins cause cancer? A meta-analysis of large randomized clinical trials
Jacques Lelorier
The American Journal of Medicine, 2001
View PDFchevron_right
Statins and Liver Toxicity: A Meta-Analysis
Andrew Peterson
Pharmacotherapy, 2004
View PDFchevron_right
Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis
David Prieto-Merino
BMC Medicine, 2014
View PDFchevron_right
Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
Sanjay D'Cruz
PLoS ONE, 2012
View PDFchevron_right
Statin-related adverse events: A meta-analysis
Anna Swanson, Matthew Silva
Clinical Therapeutics, 2006
View PDFchevron_right
Statins and Risk of Cholangiocarcinoma: A Systematic Review and Meta-analysis
Elizabeth Aby
Journal of Gastrointestinal and Liver Diseases
View PDFchevron_right
Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials
Ian Douglas
British Journal of Clinical Pharmacology, 2009
View PDFchevron_right
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
Jordan Fulcher
American Heart Journal, 2016
View PDFchevron_right
Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
Mohammad Tavakkoli
American Journal of Epidemiology, 2012
View PDFchevron_right
Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies
Alberico Catapano
Cancer Medicine, 2015
View PDFchevron_right
Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance
Richard A Krasuski
The American journal of cardiology, 2017
View PDFchevron_right
L‐TRUST: Long‐term risk of cancer in patients under statins therapy. A systematic review and meta‐analysis
Nuno Craveiro
Pharmacoepidemiology and Drug Safety, 2019
View PDFchevron_right
Real-world Evidence for Preventive Effects of Statins on Cancer Incidence: A Trans-Atlantic Analysis
Benedikt Kortüm
2021
View PDFchevron_right
Impact of statin dose on major cardiovascular events: A mixed treatment comparison meta-analysis involving more than 175,000 patients
Patricia Ziegelmann
International Journal of Cardiology, 2013
View PDFchevron_right
Statins and All-Cause Mortality in High-Risk Primary Prevention of Patients With Cardiovascular Risk Factors
Sebhat Erqou, Kausik Ray
Archives of Internal Medicine, 2010
View PDFchevron_right
Statins and Cancer Prevention—Association Does Not Mean Causation
Sanjay Das
Cancer Prevention Research
View PDFchevron_right
Statins and the Risk of Colorectal Cancer: A Meta-Analysis of 18 Studies Involving More Than 1.5 Million Patients
Christodoulos Flordellis
Journal of Clinical Oncology, 2007
View PDFchevron_right
Prevalence of statin intolerance: a meta-analysis
Peter E Penson
European heart journal, 2022
View PDFchevron_right
Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol Level
Teemu Murtola
Cancers
View PDFchevron_right
Statins and Risk of Cancer
Claudio Marelli
Journal of the American College of Cardiology, 2011
View PDFchevron_right
Clinical Outcomes in Statin Treatment Trials
Don Luo
Archives of Internal Medicine, 1999
View PDFchevron_right
Statin Use and Reduced Cancer-Related Mortality A BS T R AC T BACKGROUND
dida dlo
View PDFchevron_right
Role of Statins in the Primary Prevention of Atherosclerotic Cardiovascular Disease and Mortality in the Population with Mean Cholesterol in the Near-Optimal to Borderline High Range: A Systematic Review and Meta-Analysis
Sanjay Srivatsa
2020
View PDFchevron_right
Incidence of cancer and statin usage���Record linkage study
Jari Tiihonen
International Journal of Cancer, 2010
View PDFchevron_right
Do statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials
Rita Poushuju
Saudi medical journal, 2016
View PDFchevron_right
Meta-Analysis of Statin Effects in Women Versus Men
javier cabrera
Journal of the American College of Cardiology, 2012
View PDFchevron_right
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
Patricia Kearney
The Lancet, 2005
View PDFchevron_right
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
Isabella Ghement
QJM, 2011
View PDFchevron_right